NCT03638960View on ClinicalTrials.gov

Interscalene Single Shot With Plain Bupivacaine Versus Liposomal Bupivacaine for Arthroscopic Shoulder Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 21, 2019

Primary Completion Date

January 11, 2023

Study Completion Date

June 6, 2023

Conditions
Shoulder PainPostoperative Pain
Interventions
DRUG

Bupivacaine liposome

The investigators will perform an ultrasound-guided interscalene peripheral nerve block with either liposomal bupivacaine prior to the patient receiving surgery.

DRUG

Bupivacaine Hydrochloride

The investigators will perform an ultrasound-guided interscalene peripheral nerve block with either plain bupivacaine prior to the patient receiving surgery.

Trial Locations (1)

90033

University of Southern California, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT03638960 - Interscalene Single Shot With Plain Bupivacaine Versus Liposomal Bupivacaine for Arthroscopic Shoulder Surgery | Biotech Hunter | Biotech Hunter